Abstract
Forty female patients with 15 malignant breast tumours and 25 benign growths, all verified histologically, were studied before surgery using mammography and 111In-Bleomycin scintigraphy. The patient was studied lying prone on a table with an opening so that one breast could hang in front of the gamma camera. The true positive and negative scintigraphy results are slightly poorer (70%) than the mammography results (80%) and there are more false negative scintigraphy interpretations mostly in small lesions.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Burton, I.E., Todd, J.H., Turner, R.L.: Static and dynamic imaging with indium-111 labelled Bleomycin in the localization of squamous cell neoplasia. Br. J. Radiol. 50, 508–512 (1977)
Grove, R.B., Reba, R.C., Eckelman, W.C., Goodyear, M.: Clinical evaluation of radiolabelled Bleomycin (Bleo) for tumor detection. J. Nucl. Med. 15, 386–390 (1974)
Lilien, D.L., Jones, S.E., O'Mara, R.E., Salmon, S.E., Durie, R.E.: A clinical evaluation of indium-111 Bleomycin as a tumorimaging agent. Cancer 35, 1036–1049 (1975)
Livingstone, R.B., Fee, W.H., Einhorn, L.H., Burgess, M.A., Freireich, E.J., Gottlieb, J.A., Farber, M.O.: Bacon (bleomycin, adriamycin, CCNU, oncovin and nitrogen mustard) in squamous lung cancer. Cancer 37, 1237–1242 (1976)
Silverstein, M.J., Verma, R.C., Greenfield, L., Morton, D.L.: 111Indium-Bleomycin breast and axilla imaging. Cancer 37, 36–42 (1976)
Williams, E.D., Merrick, M.V., Lavender, J.P.: The distribution and dosimetry of 111In-Bleomycin in man. Br. J. Radiol. 48, 275–278 (1975)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Soimakallio, S., Kiuru, A. 111In-bleomycin imaging of breast tumours. Eur J Nucl Med 5, 369–371 (1980). https://doi.org/10.1007/BF00445624
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00445624